Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real‐world study

Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real‐world study

Abstract Introduction The effectiveness and safety of immune checkpoint inhibitor (ICI) monotherapy in advanced upper tract urothelial carcinoma (UTUC) is less reported. Methods In total, 106 consecutive advanced UTUC patients receiving ICI monotherapy were collected from nine high volume centers. C...

Full description

Bibliographic Details
Main Authors: Ruopeng Su, Zeyu Chen, Daoping Hong, Shuai Jiang, Yichu Yuan, Xingyun Cai, Hailong Hu, Changde Fu, Zhiyang Huang, Zhenyu Wang, Bing Zheng, Jian Huang, Zaoyu Wang, Yige Bao, Ming Cai, Jianming Guo, Minfeng Chen, Qiang Wei, Jiwei Huang, Wei Xue
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Cancer Medicine
Subjects:
advanced UTUC
cisplatin‐ineligible
immune checkpoint inhibitor
Online Access:https://doi.org/10.1002/cam4.5796

Internet

https://doi.org/10.1002/cam4.5796

Similar Items